| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/20/2004 | CA2231632C Use of creatine analogues for the treatment of disorders of glucose metabolism |
| 01/20/2004 | CA2123051C Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments |
| 01/15/2004 | WO2004005881A2 Methods for identification of compounds modulating insulin resistance |
| 01/15/2004 | WO2004005550A2 Method of screening for antidiabetic agents |
| 01/15/2004 | WO2004005510A1 NOVEL Nogo RECEPTOR-LIKE POLYPEPTIDE AND DNA THEREOF |
| 01/15/2004 | WO2004005497A1 Method of screening insulin resistance improving drug |
| 01/15/2004 | WO2004005342A1 Glp-1 and methods for treating diabetes |
| 01/15/2004 | WO2004005337A1 Phosphoinositolglycan (pig)-binding protein from adipocytes |
| 01/15/2004 | WO2004005314A1 ESTRIENO[3,2-b]/[3,4-c]PYRROLE DERIVATIVES USEFUL AS MODULATORS OF THE ESTROGEN RECEPTORS |
| 01/15/2004 | WO2004005299A1 Polymorphic forms of a 4h-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide derivative |
| 01/15/2004 | WO2004005277A1 Novel compunds, pharmaceutical compositions containing same, and methods of use for same |
| 01/15/2004 | WO2004005276A1 Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives |
| 01/15/2004 | WO2004005266A1 Oxazole derivatives and their use as insulin sensitizers |
| 01/15/2004 | WO2004005265A1 Quinazoline derivatives |
| 01/15/2004 | WO2004005262A2 New neuropeptide y y5 receptor antagonists |
| 01/15/2004 | WO2004005257A1 Secondary amino anilinic piperidines as mch1 antagonists and uses thereof |
| 01/15/2004 | WO2004005253A1 Indolin phenylsulfonamide derivatives |
| 01/15/2004 | WO2004005252A1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 01/15/2004 | WO2004005250A1 Hmg-coa reductase inhibitors |
| 01/15/2004 | WO2004005247A1 Diphenylazetidinone derivatives for treating disorders of the lipid metabolism |
| 01/15/2004 | WO2004005243A2 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives |
| 01/15/2004 | WO2004005237A1 Method of preparing hydroxytyrosol esters, esters thus obtained and use of same |
| 01/15/2004 | WO2004004778A1 Use of cetp inhibitors and optionally hmg coa reductable inhibitors and/or antihypertensive agents |
| 01/15/2004 | WO2004004777A1 Use of cetp inhibitors and antihypertensive agents as well as optionally hmg coa reductase inhibitors |
| 01/15/2004 | WO2004004774A2 Compositions comprising panthetine for the treatment of dyslipidemia |
| 01/15/2004 | WO2004004772A1 Remedy for diabetes |
| 01/15/2004 | WO2004004736A1 Novel use of imidazotriazinones |
| 01/15/2004 | WO2004004733A1 7,8,9,10-tetrahydro-6h-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2h-pyrrolo[2,1-b]-quinazolinone derivatives |
| 01/15/2004 | WO2004004726A1 Mchir antagonists |
| 01/15/2004 | WO2004004722A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(nk-1) antagonists for the treatment of emesis, depression, anxiety and cough |
| 01/15/2004 | WO2004004703A1 m-PHENYLENEDIAMINE DERIVATIVE |
| 01/15/2004 | WO2004004698A2 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity |
| 01/15/2004 | WO2004004665A2 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 01/15/2004 | WO2004004656A2 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
| 01/15/2004 | WO2004004648A2 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 01/15/2004 | WO2004004633A2 Use of tnfalpha antibodies and another drug |
| 01/15/2004 | WO2004004629A2 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 01/15/2004 | WO2003094831A3 Novel diazabicyclic biaryl derivatives |
| 01/15/2004 | WO2003092608A3 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
| 01/15/2004 | WO2003089434A3 IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES METHOD OF MAKING AND METHOD OF USE THEREOF |
| 01/15/2004 | WO2003084936A8 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological |
| 01/15/2004 | WO2003082191A3 Substituted 2,3-diphenyl pyridines |
| 01/15/2004 | WO2003080118A3 Combination of an aldosterone receptor antagonist and a fibric acid derivative |
| 01/15/2004 | WO2003079969A3 Compositions and methods for treating and preventing necrosis |
| 01/15/2004 | WO2003060130A3 Pim-3 kinase as a target for type 2 diabetes mellitus |
| 01/15/2004 | WO2003057170A8 Oral insulin therapy |
| 01/15/2004 | WO2003057148A3 Use of biomolecular targets in the treatment and visualization of tumors |
| 01/15/2004 | WO2003055992A3 A method for the establishment of a pluripotent human blastocyst-derived stem cell line |
| 01/15/2004 | WO2003019146A3 High throughput screening assays using fatty acid synthetic enzymes |
| 01/15/2004 | WO2002096866A3 Thiolalkyl benzoic acid derivatives |
| 01/15/2004 | WO2002080966A8 Method for producing a vaccine containing autologous antibodies |
| 01/15/2004 | US20040010148 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders |
| 01/15/2004 | US20040010141 Antiinflammatory agents; anticancer agents; rheumatic disorders; cardiovascular disorders |
| 01/15/2004 | US20040010134 Albumin fusion proteins |
| 01/15/2004 | US20040010118 Novel proteins and nucleic acids encoding same |
| 01/15/2004 | US20040010023 Biphenyl derivatives and the use thereof as integrin inhibitors |
| 01/15/2004 | US20040010020 Trifluoromethyl-substituted nitrogen compounds; treating type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumors, and glaucoma |
| 01/15/2004 | US20040010013 Cannabinoid receptor ligands |
| 01/15/2004 | US20040010010 Melanocortin receptor ligands |
| 01/15/2004 | US20040009998 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 01/15/2004 | US20040009997 Treating diseases in which HMG CoA reductase is implicated, such as hyperlipidemia, hypercholesterolemia and atherosclerosis |
| 01/15/2004 | US20040009996 4-(1,2- or 2,1-benzoxazol-5-yl)-2-aminopyrimidines |
| 01/15/2004 | US20040009995 Treating the symptoms of an acute or chronic disorder mediated by the classical pathway of the complement cascade |
| 01/15/2004 | US20040009994 Use of estrogen antagonists and estrogen agonists inhibiting pathological conditions |
| 01/15/2004 | US20040009988 Inhibiting hepatic production of apoprotein B-100 and microsomal triglyceride transfer protein to decrease VLDL and chylomicrons production |
| 01/15/2004 | US20040009986 Triglyceride depressant composition |
| 01/15/2004 | US20040009984 Increasing levels of endogenous growth hormone, especially treating osterporosis, aging frailty or congestive heart failure |
| 01/15/2004 | US20040009983 Azaindoles |
| 01/15/2004 | US20040009981 Oxazole, thiazole, 1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives of pyrimidines, 1,2,4- and 1,3,5-triazines |
| 01/15/2004 | US20040009980 Calcilytic compounds |
| 01/15/2004 | US20040009979 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 01/15/2004 | US20040009974 Pyrimidylamino- or triazinylamino- substituted pyrazoles or 1,2,3-triazoles |
| 01/15/2004 | US20040009970 5HT2c agonists or partial agonists; e.g., 4,5,6,7,9a,10,11,12,13,13a-decahydro-9H-(1,4)diazepino-(6,7,1 -de)phenanthridine hydrochloride |
| 01/15/2004 | US20040009968 Indazole compounds useful as protein kinase inhibitors |
| 01/15/2004 | US20040009965 Treating hyperproliferative disorders |
| 01/15/2004 | US20040009961 Composition and therapies for hyperlipidaemia-associated disorders |
| 01/15/2004 | US20040009907 Nucleic acids encoding cytoplasmic, nuclear, membrane bound, and secreted polypeptides, as well as vectors, host cells, antibodies, and recombinant methods for production |
| 01/15/2004 | US20040009905 Templates consist of cyclized peptides containing at least two residues in said cyclized peptide are joined by a naphthyl ring; and having bonded to it a linear peptide |
| 01/15/2004 | US20040009901 Identifying and administering an agent that enhances NADPH oxidase activity; diagnosing an autoimmune condition accompanied by NADPH oxidase deficiency |
| 01/15/2004 | US20040009244 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 01/15/2004 | US20040009216 Administering liposomes comprising phospholipids and an aqueous layer, said liposomes having specified average diameter; treating various cardiovascular disorders, reducing cholesterol |
| 01/15/2004 | US20040009167 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism |
| 01/15/2004 | US20040009125 First series of intranasal administration of E-selectin over period of two weeks, followed by a booster administration of E-selectin after at least two weeks from the first administration of E-selectin to minimize brain tissue damage |
| 01/15/2004 | DE10227232A1 Saure Insulinzubereitungen mit verbesserter Stabilität Acidic insulin preparations with improved stability |
| 01/15/2004 | CA2767092A1 Novel compounds, pharmaceutical compositions containing same and methods of use for same |
| 01/15/2004 | CA2493906A1 Therapeutics for diabetes mellitus |
| 01/15/2004 | CA2492162A1 Hmg-coa reductase inhibitors |
| 01/15/2004 | CA2492121A1 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 01/15/2004 | CA2492010A1 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity |
| 01/15/2004 | CA2491998A1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 01/15/2004 | CA2491835A1 Mch1r antagonists |
| 01/15/2004 | CA2491789A1 Diphenylazetidinone derivatives for treating disorders of the lipid metabolism |
| 01/15/2004 | CA2491477A1 Indolin phenylsulfonamide derivatives |
| 01/15/2004 | CA2491464A1 Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives |
| 01/15/2004 | CA2491455A1 Novel use of imidazotriazinones |
| 01/15/2004 | CA2491417A1 Method for screening an agent for improving insulin resistance |
| 01/15/2004 | CA2491406A1 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
| 01/15/2004 | CA2491382A1 Compositions comprising panthetine for the treatment of dyslipidemia |
| 01/15/2004 | CA2491132A1 Estrieno[3,2-b]/[3,4-c]pyrrole derivatives useful as modulators of the estrogen receptors |
| 01/15/2004 | CA2491127A1 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |